Using heart rate variability biofeedback to help with substance use disorder recovery
A pilot study of ambulatory Heart Rate Variability Biofeedback for substance use disorder
['FUNDING_R21'] · MASSACHUSETTS GENERAL HOSPITAL · NIH-10837428
This study is looking at how a special breathing technique can help people in early recovery from substance use disorder better handle tough emotions and situations that might make them want to use again, so they can stay on track with their recovery goals.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS GENERAL HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10837428 on ClinicalTrials.gov |
What this research studies
This research investigates how heart rate variability biofeedback can help individuals in early recovery from substance use disorder manage negative emotions and triggers that lead to substance use. By training patients to control their physiological responses, the study aims to enhance their ability to resist urges and maintain their recovery goals. Participants will learn techniques to improve their emotional regulation and cognitive control, potentially leading to better outcomes in their recovery journey.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in early recovery from substance use disorder who experience negative emotions and triggers related to substance use.
Not a fit: Patients who are not in recovery from substance use disorder or who do not experience significant emotional triggers related to substance use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with effective tools to manage cravings and improve their recovery from substance use disorders.
How similar studies have performed: Previous research has shown promise in using biofeedback techniques for emotional regulation, suggesting that this approach may be beneficial for substance use disorder treatment.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS GENERAL HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: EDDIE, DAVID — MASSACHUSETTS GENERAL HOSPITAL
- Study coordinator: EDDIE, DAVID
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.